Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2.

Guo, Liping; Liu, Xue; Gu, Yuchen; Jiang, Jinyan; Yang, Ziyue; Lv, Qiuying; Guo, Deyin; Yang, Yang; Lu, Hongzhou; Yuan, Jing

Guo, Liping; Liu, Xue; Gu, Yuchen; Jiang, Jinyan; Yang, Ziyue; Lv, Qiuying; Guo, Deyin; Yang, Yang; Lu, Hongzhou; Yuan, Jing.

Guo L; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Liu X; Centre for Infection and Immunity Study (CIIS), School of Medicine (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China.
Gu Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Jiang J; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Yang Z; Centre for Infection and Immunity Study (CIIS), School of Medicine (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China.
Lv Q; Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
Guo D; Centre for Infection and Immunity Study (CIIS), School of Medicine (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China.
Yang Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China. yyszth2018@163.com.
Lu H; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China. luhongzhou@szsy.sust
Yuan J; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China. 13500054798@139.com.

Signal Transduct Target Ther ; 8(1): 171, 2023 04 26.

Artigo em Inglês | MEDLINE | ID: covidwho-2295931

Assuntos

COVID-19; Humanos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Estudo prognóstico Limite: Humanos Idioma: Inglês Revista: Signal Transduct Target Ther Ano de publicação: 2023 Tipo de documento: Artigo País de afiliação: S41392-023-01443-2

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google